37
Participants
Start Date
October 15, 2025
Primary Completion Date
February 28, 2031
Study Completion Date
February 28, 2031
Belumosudil
Pharmaceutical form:Oral suspension -Route of administration:Oral or nasogastric tube
Belumosudil
Pharmaceutical form:Tablet formulation-Route of administration:Oral
Lead Sponsor
Sanofi
INDUSTRY